Amdocs logo

DOX - Amdocs Share Price

$70.78 -0.1  -0.1%

Last Trade - 22/01/21

Large Cap
Market Cap £6.77bn
Enterprise Value £6.62bn
Revenue £3.04bn
Position in Universe 931st / 6626
Unlock DOX Revenue
Relative Strength (%)
1m -1.85%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -8.32%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 30th Sep 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
3,644 3,718 3,867 3,975 4,087 4,169 4,411 4,594 +2.7%
+11.5 -7.2 +9.4 +2.0 +14.9 +6.8 +28.3 +7.21
Balance Sheet
FINANCIAL BRIEF: : For the fiscal year ended 30 September 2020, AmdocsLimited revenues increased 2% to $4.17B. Net incomeapplicable to common stockholders increased 4% to $494.2M.Revenues reflect Managed services arrangement segmentincrease of 7% to $2.4B, North America segment increase of5% to $2.72B, Europe segment increase of 3% to $613.8M. Netincome benefited from Other Selling,general and adminExpenses decrease of 8% to $439.2M (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Latest News & Insights for DOX
Graphical History


DOX Revenue Unlock DOX Revenue

Net Income

DOX Net Income Unlock DOX Revenue

Normalised EPS

DOX Normalised EPS Unlock DOX Revenue

PE Ratio Range

DOX PE Ratio Range Unlock DOX Revenue

Dividend Yield Range

DOX Dividend Yield Range Unlock DOX Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
DOX EPS Forecasts Unlock DOX Revenue
Profile Summary

Amdocs Limited is a provider of software and services for communications, pay television (TV), entertainment and media industries and other service providers. The Company’s offerings are based on a product and services mix, using technologies and methodologies such as cloud, microservices, development and operations (DevOps), open source, bimodal operations, site reliability engineering (SRE) and automation through standard information technology (IT) tools, open application programming interfaces (APIs) and artificial intelligence (AI).The Company’s services include managed services, digital business operations, quality engineering services, cloud services, consulting services, integration services, and data and intelligence services. The Company also provides fifth generation (5G) charging, policy and cloud-native technologies.

Last Annual September 30th, 2020
Last Interim September 30th, 2020
Incorporated September 28, 1988
Public Since June 19, 1998
No. of Shareholders: 1,595
No. of Employees: 25,875
Sector Technology
Industry Software & IT Services
Index Nasdaq Composite ,
Exchange NASDAQ Global Select Market
Shares in Issue 131,110,182
Free Float (0.0%)
Eligible for
DOX Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for DOX
Upcoming Events for DOX
Tuesday 2nd February, 2021 Estimate
Q1 2021 Amdocs Ltd Earnings Release
Wednesday 5th May, 2021 Estimate
Q2 2021 Amdocs Ltd Earnings Release
Frequently Asked Questions for Amdocs
What is the Amdocs share price?

As of 22/01/21, shares in Amdocs are trading at $70.78, giving the company a market capitalisation of £6.77bn. This share price information is delayed by 15 minutes.

How has the Amdocs share price performed this year?

Shares in Amdocs are currently trading at $70.78 and the price has moved by -4.73% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Amdocs price has moved by -17.75% over the past year.

What are the analyst and broker recommendations for Amdocs?

Of the analysts with advisory recommendations for Amdocs, there are there are currently 4 "buy" , 2 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Amdocs is Buy. You can view the full broker recommendation list by unlocking its StockReport.

When will Amdocs next release its financial results?

Amdocs is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-09-30
What is the Amdocs dividend yield?

The Amdocs dividend yield is 1.73% based on the trailing twelve month period.

Does Amdocs pay a dividend?

Last year, Amdocs paid a total dividend of 1.23, and it currently has a trailing dividend yield of 1.73%. Looking ahead, Amdocs has not announced an ex-dividend date yet and the next dividend pay date is 2021-01-22.

When does Amdocs next pay dividends?

Amdocs has yet to annouce their ex-dividend date and the next dividend pay date is 2021-01-22. The historic dividend yield on Amdocs shares is currently 1.73%.

How do I buy Amdocs shares?

To buy shares in Amdocs you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Amdocs?

Shares in Amdocs are currently trading at $70.78, giving the company a market capitalisation of £6.77bn.

Where are Amdocs shares listed? Where are Amdocs shares listed?

Here are the trading details for Amdocs:

Country of listing: United States
Exchange: NSQ
Ticker Symbol: DOX
What kind of share is Amdocs?

Based on an overall assessment of its quality, value and momentum, Amdocs is currently classified as a Style Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Amdocs share price forecast 2021?

Shares in Amdocs are currently priced at $70.78. At that level they are trading at 7.86% discount to the analyst consensus target price of 0.00.

Analysts covering Amdocs currently have a consensus Earnings Per Share (EPS) forecast of 4.759 for the next financial year.

How can I tell whether the Amdocs share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Amdocs. Over the past six months, the relative strength of its shares against the market has been -1.53%. At the current price of $70.78, shares in Amdocs are trading at 14.04% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Amdocs PE Ratio?

The Amdocs PE ratio based on its reported earnings over the past 12 months is 19.11. The shares are currently trading at $70.78.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of Amdocs?

Amdocs's management team is headed by:

Robert Minicucci - NEC
Eliahu Gelman - DRC
Giora Yaron - DRC
Tamar Rapaport-Dagim - CFO
Shuky Sheffer - PRE
Matthew Smith - DIR
Rajat Raheja - CEX
Rafael de la Vega - IND
Yvette Kanouff - DRC
Who are the major shareholders of Amdocs?

Here are the top five shareholders of Amdocs based on the size of their shareholding:

Fidelity Management & Research Company LLC Investment Advisor
Percentage owned: 11.34% (14.9m shares)
Janus Henderson Investors Investment Advisor/Hedge Fund
Percentage owned: 5.19% (6.81m shares)
LSV Asset Management Investment Advisor
Percentage owned: 4.87% (6.38m shares)
Janus Henderson Enterprise Fund Mutual Fund
Percentage owned: 4.18% (5.48m shares)
Wells Capital Management Inc. Investment Advisor/Hedge Fund
Percentage owned: 3.86% (5.06m shares)
Similar to DOX
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.